Prevalence and identification of type 1 diabetes in Chinese adults with newly diagnosed diabetes

References

• Yang Z , Wang K , Li T , et al. Childhood diabetes in China. Enormous variation by place and ethnic group. Diabetes Care . 1998;21:525–529. doi:10.2337/diacare.21.4.525 9571336
   PubMed Web of Science ®Google Scholar
• Weng J , Zhou Z , Guo L , et al. Incidence of type 1 diabetes in China, 2010-13: population based study. BMJ . 2018;360:j5295. doi:10.1136/bmj.j5295 29298776
   PubMed Web of Science ®Google Scholar
• Palmer JP , Hampe CS , Chiu H , Goel A , Brooks-Worrell BM . Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age? Diabetes . 2005;54(Suppl 2):S62–S67. doi:10.2337/diabetes.54.suppl_2.s62 16306342
   PubMed Web of Science ®Google Scholar
• Alberti KG , Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med . 1998;15:539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 9686693
   PubMed Web of Science ®Google Scholar
• Haffner SM ; American Diabetes Association. Dyslipidemia management in adults with diabetes. Diabetes Care . 2004;27 Suppl 1:S68–S71. doi:10.2337/diacare.27.2007.s68 14693930
   PubMedGoogle Scholar
• Chinese Diabetes Society. China guideline for type 2 diabetes. Chin J Diabetes Mellitus . 2014;6:447–498.
   Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panal on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panal III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panal on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panal III) final report. Circulation. 2002;106:3143–3421.
   Google Scholar
• Zhou Z , Xiang Y , Ji L , et al. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study. Diabetes . 2013;62:543–550. doi:10.2337/db12-0207 23086039
   PubMed Web of Science ®Google Scholar
• Xu Y , Wang L , He J , et al.; China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults. JAMA . 2013;310:948–959. doi:10.1001/jama.2013.168118 24002281
   PubMed Web of Science ®Google Scholar
• Yang XL , Ma RC , So WY , Kong AP , Xu G , Chan JC . Addressing different biases in analysing drug use on cancer risk in diabetes in non-clinical trial settings–what, why and how? Diabetes Obes Metab . 2012;14:579–585. doi:10.1111/j.1463-1326.2011.01551.x 22171706
   PubMed Web of Science ®Google Scholar
• Takeda H , Kawasaki E , Shimizu I , et al. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). Diabetes Care . 2002;25:995–1001. doi:10.2337/diacare.25.6.995 12032105
   PubMed Web of Science ®Google Scholar
• Park Y , Hong S , Park L , et al. LADA prevalence estimation and insulin dependency during follow-up. Diabetes Metab Res Rev . 2011;27:975–979. doi:10.1002/dmrr.1278 22069296
   PubMed Web of Science ®Google Scholar
• Guglielmi C , Palermo A , Pozzilli P . Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy. Diabetes Metab Res Rev . 2012;28(Suppl 2):40–46. doi:10.1002/dmrr.2345
   Web of Science ®Google Scholar
• Zinman B , Kahn SE , Haffner SM , et al. Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes . 2004;53:3193–3200. doi:10.2337/diabetes.53.12.3193 15561950
   PubMed Web of Science ®Google Scholar
• Turner R , Stratton I , Horton V , et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet . 1997;350:1288–1293. doi:10.1016/s0140-6736(97)03062-6 9357409
   PubMed Web of Science ®Google Scholar
• Tuomi T , Carlsson A , Li H , et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes . 1999;48:150–157. doi:10.2337/diabetes.48.1.150 9892237
   PubMed Web of Science ®Google Scholar
• Hawa MI , Buchan AP , Ola T , et al. LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes. Diabetes Care . 2014;37:1643–1649. doi:10.2337/dc13-2383 24722498
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. IDF Diabetic Atlas 8th edition; 2017 Available from: http://www.diabetesatlas.org/resources/2017-atlas.html/. [Accessed 5 22, 2018].
   Google Scholar
• Carlsson S , Midthjell K , Tesfamarian MY , Grill V . Age, overweight and physical inactivity increase the risk of latent autoimmune diabetes in adults: results from the Nord-Trondelag health study. Diabetologia . 2007;50:55–58. doi:10.1007/s00125-006-0518-7 17096113
   PubMed Web of Science ®Google Scholar
• Hjort R , Ahlqvist E , Carlsson PO , et al. Overweight, obesity and the risk of LADA: results from a Swedish case-control study and the Norwegian HUNT Study. Diabetologia . 2018;61:1333–1343. doi:10.1007/s00125-018-4596-0 29589073
   PubMed Web of Science ®Google Scholar
• Hamilton J , Cummings E , Zdravkovic V , Finegood D , Daneman D . Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care . 2003;26:138–143. doi:10.2337/diacare.26.1.138 12502670
   PubMed Web of Science ®Google Scholar
• Kobayashi T , Nakanishi K , Murase T , Kosaka K . Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes . 1996;45:622–626. doi:10.2337/diab.45.5.622 8621013
   PubMed Web of Science ®Google Scholar
• Maruyama T , Tanaka S , Shimada A , et al. Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus. J Clin Endocrinol Metab . 2008;93:2115–2121. doi:10.1210/jc.2007-2267 18397986
   PubMed Web of Science ®Google Scholar
• Fourlanos S , Perry C , Stein MS , Stankovich J , Harrison LC , Colman PG . A clinical screening tool identifies autoimmune diabetes in adults. Diabetes Care . 2006;29:970–975. doi:10.2337/diacare.295970 16644622
   PubMed Web of Science ®Google Scholar